中國奧園(03883.HK):奧園美谷擬轉讓物業開發業務以專注醫療美容業務發展
格隆匯4月29日丨中國奧園(03883.HK)發佈公吿,奧園美谷(000615.SZ)(公司間接非全資附屬公司)正考慮進行其於若干附屬公司及╱或聯營公司(主要從事物業開發)的部分或全部股權的潛在轉讓。於本公吿日期,潛在轉讓的確切目標公司、潛在轉讓的代價、承讓人身份及交易方式尚未確定。
奧園美谷主要從事物業開發、綠纖新材料的生產與銷售以及醫療美容業務。於本公吿日期,奧園美谷由公司間接全資附屬公司深圳奧園科星投資有限公司擁有約29.34%。由於集團為單一最大股東並獲得奧園美谷的控制權,奧園美谷為公司非全資附屬公司,其財務業績根據國際財務報吿準則併入集團的財務報表。
預期於完成潛在轉讓後,奧園美谷及其附屬公司將專注於綠纖新材料及醫療美容業務的經營及發展,有利於推進奧園美谷戰略性轉型及可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.